
Nucyreta 50mg Tablet ER
Marketer
Taj Pharma India Ltd
Salt Composition
Tapentadol (50mg)
Overview Nucyreta 50mg Tablet ER
Extended-release Nucyreta 50mg tablets provide relief from moderate to severe acute pain in adults. This medication addresses various pain types, including headaches, fever, menstrual cramps, dental pain, and common cold symptoms. It's indicated when other analgesics prove ineffective. Dosage and treatment duration should strictly follow your physician's instructions. This medication carries a significant risk of dependence. Potential side effects include nausea, somnolence, emesis, and vertigo. Patients with pre-existing cardiac, hepatic, or renal conditions should inform their doctor. Pregnant women, those intending to conceive, and breastfeeding mothers must consult their physician before use.
Primary Ingredients of Nucyreta 50mg Tablet ER
There is no text provided to rephrase.
Uses of Nucyreta 50mg Tablet ER
Significant to intense pain
Major Benefits of Nucyreta 50mg Tablet ER:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nucyreta 50mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Nucyreta 50mg Tablet ER:
- Nausea
- Vomiting
- Dizziness
- Sleepiness
How to use Nucyreta 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Nucyreta 50mg Extended-Release Tablets. Ingest the tablet whole; avoid chewing, crushing, or fracturing. While consumption with or without food is acceptable, consistent daily timing is recommended.
How Nucyreta 50mg Tablet ER works:
Extended-release Nucyreta 50mg tablets reduce pain sensation by interrupting the pathway of pain signals to the brain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Nucyreta 50mg Extended-Release Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Nucyreta 50mg tablets might pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Nucyreta 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk with the possibility of infant harm.
DrivingUNSAFE
Driving may be impaired by Nucyreta 50mg Extended-Release Tablets, which can induce side effects. Refrain from operating a vehicle if drowsiness, dizziness, blurred vision, or slowed reflexes occur while using Nucyreta 50mg Extended-Release Tablets.
KidneyCAUTION
Extended-release Nucyreta 50mg tablets require careful administration in individuals with impaired kidney function. Dosage modification of Nucyreta 50mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Extended-release Nucyreta 50mg tablets require careful administration for individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Nucyreta 50mg extended-release tablets are contraindicated in patients exhibiting severe renal dysfunction.
What if you forget to take Nucyreta 50mg Tablet ER :
Omit any missed dose of Nucyreta 50mg Extended-Release Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nucyreta 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Phenylpropanoid |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
